Cite
HARVARD Citation
Dou, J. et al. (2018). Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double‐blind, active‐controlled, phase 3 trial. Diabetes, obesity & metabolism. 20 (3), pp. 590-598. [Online].